PIVOT HD
A study to evaluate the safety and efficacy of PTC518 in participants with Huntington's disease (HD)
Phase 2 study testing PTC518 to see whether it can slow the progression of Huntington's disease.
Recruitment endedPhase IINot specifiedISRCTNTreatment trial
Recruiting in: United States
Preparing a short plain-English summary.